Seeking FDA guidance on DMOAD labelling as soon as canine study out.
This should stop them going down rabbit holes and allow them to set clear expectations on future pricing, take-up and TAM
- Forums
- ASX - By Stock
- PAR
- Ann: NWR Virtual Healthcare Conference Presentation
Ann: NWR Virtual Healthcare Conference Presentation, page-18
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
30.0¢ |
Change
-0.010(3.23%) |
Mkt cap ! $104.9M |
Open | High | Low | Value | Volume |
31.0¢ | 31.5¢ | 29.0¢ | $161.3K | 527.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 10756 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 62010 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 10756 | 0.300 |
1 | 99965 | 0.295 |
5 | 87991 | 0.290 |
3 | 38593 | 0.285 |
3 | 110000 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 50010 | 2 |
0.320 | 45000 | 2 |
0.325 | 50366 | 4 |
0.330 | 125773 | 4 |
0.335 | 10000 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online